Chemical and enzymic cleavages of the F~ subunit of the fusion (F) protein of respiratory syncytial (RS) virus showed that the sequence 184-Gly to 314-Trp reacted with neutralizing monoclonal antibodies (MAbs). Twelve synthetic peptides covering a part of this sequence were analysed for their immunoreactivity with neutralizing MAbs and anti-RS virus rabbit serum. Two sequential antigenic domains corresponding to amino acids 200 to 225 and 255 to 278 were defined with anti-RS virus rabbit serum. The peptides 205-225 and 259-278, belonging to these antigenic domains, inhibited binding to the F protein and the neutralizing activity of the anti-RS virus rabbit serum. One MAb (RS-348) reacted with peptides containing amino acids 200 to 225. Moreover, the peptide 205-225 induced an anti-peptide rabbit serum neutralizing RS virus in vitro. These results indicate that the sequence from residues 200 to 225 was present in one of the immunodominant sites of the F protein.
Introduction
Human respiratory syncytial (RS) virus, which is in the pneumovirus genus of the Paramyxoviridae family, is a major cause of lower respiratory tract infections in young children (Kim et al., 1973) . The role of immune mechanisms in human diseases has not been clarified. Previous attemps to develop effective vaccines with attenuated or killed RS virus have met with failure. Not only were the children unprotected, but subsequent infections with RS virus sometimes resulted in more severe diseases than in non-immunized controls. In addition, primary infection gives an incomplete immunity and reinfection is frequently observed during childhood.
Recently, immunological and molecular information has been obtained regarding the antigenic and functional properties of RS virus proteins. The fusion protein (F) and the attachment protein (G) have been identified as the major viral antigens, and their genes have been cloned and sequenced (Collins et al., 1984; Elango et al., 1985; Johnson & Collins, 1988; Satake et al., 1985; Wertz et al., 1985) . Two antigenically distinct subgroups of RS virus, designated A and B, have been described (Anderson et al., 1985; Mufson et al., 1985) . The antigenic differences between A and B subgroups reside mainly on the G protein (Johnson et al., 1987b) . In contrast, the F protein has a high degree of genetic and antigenic homology between the two subgroups (Johnson & Collins, 1988; Walsh et al., 1987) .
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Monoclonal antibodies (MAbs) directed against both envelope glycoproteins (F and G) of RS virus can neutralize the virus (Walsh & Hruska, 1983; Walsh et al., 1984a) . However, in vitro and in vivo studies with MAbs or with vaccinia virus recombinants expressing F protein indicated that this protein is the most important antigen in inducing cross-protective immunity (Johnson et al., 1987a; Olmsted et aL, 1986; Wertz et al., 1987; Walsh et al., 1984b) . Several authors have identified different antigenic sites in the F protein and have shown that at least three of these antigenic sites are involved in neutralization. Two or three neutralizing epitopes have been located on the F protein in different ways. Using escape mutant viruses, L6pez et al. (1990) have shown that two amino acid residues (262-Asn and 268-Asn) of the F~ subunit are essential for the integrity of a neutralizing epitope. Another highly conserved neutralizing epitope has been mapped with synthetic peptides to residues 221-Ile to 232-Glu by Trudel et al. (1987) . Finally, a recent analysis by the Pepscan procedure identified an epitope at positions 483-Phe to 488-Phe which could correspond to another neutralizing epitope (Scopes et al., 1990) .
In order to explore further the antigenicity and the immunogenicity of the F protein, we analysed the reactivity of an anti-RS virus rabbit serum and several neutralizing MAbs with synthetic peptides corresponding to a part of the F protein of the Long strain. Two peptides corresponding to the sequences 205-Pro to 225-Gin and 259-Ser to 278-Val have been identified as probable epitopes involved in neutralization.
Methods
Cells virus and Fprotein. The Long strain of RS virus was propagated on HeLa cells. The virus was concentrated by precipitation with 6~ polyethylene glycol 6000 and purified on a discontinuous 30 to 50~ sucrose gradient. The F protein was harvested after affinity chromatography (Walsh et al., 1985) on a Sepharose CNBr-activated column coupled with MAb RS-348.
Antibodies against RS virus. MAbs were obtained after immunizing mice with RS virus-infected HeLa cells mixed with Freund's adjuvant. Selection of secreting clones was by immunofluorescence or ELISA. Nine neutralizing and fusion-inhibiting MAbs were used in this study. Five of these MAbs were produced in our laboratory. They identified two antigenic sites by competitive binding assays [RS-348, 720, 18B2, 1056 (site I) ; 299 (site II)]. The other four MAbs used in this study were given to us by the Institut M6rieux (7217, 5353, 8179 and AE50). These nine neutralizing and fusion-inhibiting MAbs (IgGl) react with subgroup A and B RS virus and recognize the F, subunit of the F protein in immunoblots on nitrocellulose sheets. Anti-RS virus rabbit serum was obtained by four subcutaneous inoculations every 21 days from RS virus-infected HeLa cells.
Enzymic and chemical cleavage of the F 1 subunit. Viral proteins were first subjected to SDS-PAGE (11-5 ~ acrylamide) using the discontinuous system. The gels were stained briefly with Coomassie blue and the band containing the F~ fragment of the F protein was cut out with a razor blade. This band was transferred to vials containing the fragmentation mixture for chemical cleavage. Three chemical agents were used: hydroxylamine (NH2OH) which cleaves Asn-Gly bonds, N-chlorosuccinimide (NCS) which cleaves at tryptophan residues and HC1 which cleaves Asp-Pro bonds. For cleavage with NHzOH, gel slices were incubated for 3 h at 45 °C in a cleavage mixture containing 2 M-hydroxylamine hydrochloride (Sigma), 15 mM Tris base and 4.5 Mlithium hydroxide (Merck) (Saris et al., 1983) . For cleavage with NCS, gel slices were incubated for 30 rain at room temperature with 15 mM-NCS (Sigma) in urea/HzO/acetic acid (1 g/1 ml/1 ml) (Lischwe & Ochs, 1982) . For cleavage with HC1, the proteins were cleaved in mild acid (0.015 M) by heating at I10°C for 20 min. The reaction was stopped by rapid cooling in ice (Rittenhouse & Marcus, 1984) . After incubating for different lengths of time, the gel slices were washed and equilibrated in 10~ glycerol, 2~ 2-mercaptoethanol, 3~ SDS in 625 mM-Tris-HCl pH 6.8 before loading on a second SDS~olyacryl-amide gel (15 ~). The peptide fragments were then immunoblotted and ordered by comparing the Mrs of observed fragments and theoretical fragments deduced from the amino acid sequence of the F, subunit .
For enzymic cleavage, the band from the first gel was loaded on top of the stacking gel and overlayed with carboxypeptidase (Boehringer Mannheim). Digestion was performed during subsequent electrophoresis (Cleveland et al., 1977) .
lmmunobtotting. Peptide fragments separated by SDS-PAGE were blotted onto nitrocellulose sheets (0.10 tam; Schleicher & Schuell) in transfer buffer consisting of 25 mM-Tris-HC1 pH 8.3, 190 mM-glycine, 20% methanol. Transfer was carried out at 0.7 mA/cm 2 gel for 1 h. Non-specific absorption sites on nitrocellulose were saturated by incubation for 1 h at 37 °C in phosphate-buffered saline (PBS) containing 5~ (w/v) bovine serum albumin (BSA). The nitrocellulose strips were then washed in PBS, 1 ~ (w/v) BSA, 0.2~ (v/v) Tween 20 (PBT buffer) and incubated under mild agitation for 1 h at 37 °C with culture supernatants of hybridomas. The nitrocellulose strips were then washed three times in PBT buffer and further incubated for 1 h at 37 °C with a 1/2000 dilution of peroxidase-conjugated goat anti-mouse lgG antiserum (Bio-Rad). Specific immunoblotted bands were revealed with 0-05 % (w/v) 3,3'-diaminobenzidine tetrahydrochloride (Sigma) in Tris-HCl pH 7.6 with 0.25~ (v/v) H202. The reaction was stopped with 0.5 M H2SO 4 and the strips were washed in distilled water.
Synthetic peptides. Twelve peptides, [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268] [269] [270] [271] [272] [273] [274] [275] [276] [277] [278] [262] [263] [264] [265] [266] [267] [268] [269] [270] [271] [272] [273] [274] [275] [276] [277] [278] [275] [276] [277] [278] [279] [280] [281] [282] [283] [284] [285]  were chosen on the basis of results from F, protein cleavages and computer predictions (Macro-Bio-Soft program, Prolabo) of epitopes within the amino acid 183 to 314 region. The peptides were synthesized by a solid-phase method on a Biolynx model 4175 peptide synthesizer (Pharmacia) using N'-fluorenylmethoxycarbonyl (FMOC)-protected amino acids and a polyamide solid phase (Atherton et al., 1985) .
Acylation was performed in anhydrous dimethylformamide (DMF) using activated esters of each amino acid (3,4-dihydro 3-hydroxy 4-oxo 1,2,3-benzotriazine esters for serine and threonine, pentafluorophenol esters for the others with equimolar 1-hydroxybenzotriazole. Piperidine (20~) in DMF was used for the deprotection step. After cleavage of the terminal FMOC group, peptides were removed from the resin with 95~ aqueous trifluoroacetic acid (TFA) for 90 min except for peptides containing either 4-methoxy-2,3,6-trimethylphenyl-sulphonyl arginine, methionine or S-t-butyl cysteine residues which were removed with 95 ~ TFA in the presence of anisole and ethanedithiol for 6 h. TFA was then evaporated and the residue resuspended in distilled water before being lyophilized. Scavengers were extracted with diethylether before the aqueous layer was lyophilized. For peptides containing cysteine, the S-t-butyl protecting group was not removed. A sample of the crude peptide was then hydrolysed for amino acid and HPLC analysis.
Coupling of peptides to a carrier protein and preparation of antisera.
On the basis of the results with MAbs on coated plates, peptide 205-225 was coupled to BSA at its carboxyl group using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (Sigma). The conjugate was dialysed overnight against PBS.
Female mice (BALB/c strain) were immunized intraperitoneally with either 50 lag of peptide-BSA conjugate or 50 lag of non-conjugated peptide. Complete Freund's adjuvant was used for the first injection and incomplete Freund's adjuvant for the second, third and fourth intraperitoneal injections given at 2 week intervals. Blood was collected before the first injection and 6 days after the second, third and fourth injections. Rabbits were immunized subcutaneously with 200 lig of peptide-BSA conjugate. Complete Freund's adjuvant was used for the first injection and incomplete adjuvant for the second and third injections given at 3 week intervals. Female mice and rabbits were also immunized with virus in the same way. Binding of anti-peptide and anti-RS virus antibodies to the relevant peptides or the purified F protein was measured by ELISA.
ELISA techniques. The wells of microtitre plates were coated overnight at room temperature either with free peptides (1 lag) or with F protein purified by affinity chromatography (l lag/well), in 0.1 Mcarbonate coating buffer pH 9.6. Binding sites in the wells were saturated by incubation with 2~ non-fat milk for 30 min at 37 °C. For each assay, incubation was for 30 min at 37 °C after each addition of 100 lal of reagent per well, followed by washing with PBS (pH 7.2) containing 0.05~ Tween 20. The diluent throughout was PBS, 1~ BSA, 0-05~ Tween 20, and antisera prepared against conjugated peptides were first adsorbed on 5~ (w/v) BSA in PBS pH 7.2. The binding of antibodies to peptides or F protein and antigen inhibition assays were assessed by direct ELISA and competitive ELISA, respectively. For the direct ELISA, MAbs, anti-RS virus or antipeptide sera were incubated on wells coated with peptides or F protein. Binding of antibodies was revealed by addition of peroxidase-labelled goat antimouse IgG or anti-rabbit Ig. After addition of peroxidase substrate, absorbance was measured on a Titertek Multiskan spectrophotometer at 492 nm. The titres were expressed as the lowest log,0 of the serum dilution giving an absorbance greater than the control value of 0.100. For competitive ELISA, several dilutions of competitor antigen (F protein or peptides) were preincubated for 1 h at 37 °C with equal volumes of constant, predetermined dilutions of MAbs, anti-RS virus or anti-peptide serum in silicone-coated vials. Samples of each mixture were transferred to duplicate wells coated with peptides or F protein and incubated for 30 min at 37 °C. After washing, peroxidase-labelled goat anti-mouse IgG was employed as described above. Percentage competition was calculated by the formula 100(A -B)/A, where A is the absorbance in the absence of F protein or relevant peptide in the solution and B is the absorbance in the presence of F protein or relevant peptide in the solution.
Neutralization and inhibition of neutralization assay. Neutralization of Long RS virus was performed by a plaque reduction assay. Briefly, virus (105 p.f.u.) was mixed for 1 h with anti-RS virus or anti-peptide 205 225 rabbit sera collected 0, 52 and 73 days after immunization. These sera were decomplemented before use. Monolayers of HeLa cells in six-well plates were then infected. Neutralization was recorded when the mean loglo reciprocal of the serum dilution gave a 50~ plaque reduction.
Inhibition of Long RS virus neutralization was carried out by incubation of an appropriate dilution of the anti-RS virus rabbit serum with several dilutions of competitor antigen (peptides) before mixing it with the virus. The results were expressed as the percentage inhibition; the number of plaques per well according to the concentration of competitor peptide was compared with the number of plaques per well obtained when the virus had been preincubated with pre-immune serum in the absence of peptides.
Results

Immunoreactivity o f fragments resulting from cleavage of the FI protein
Peptide mapping of the F1 protein (48K) of RS virus by chemical cleavage (NCS, NH2OH or HC1) and carboxypeptidase yielded several fragments recognized by MAb RS-348 (Fig. 1) . The smaller fragment recognized by MAb RS-348 after cleavage by carboxypeptidase was a 24K fragment. This fragment corresponds to the half of the F1 protein not digested by carboxypeptidase. A complete digestion with NCS, which cleaves after amino acids 314 and 341 gave three fragments: 3.4K (residues 314 to 341), 24K (residues 341 to 574) and 30.5K (residues 137 to 314). In our case the 24K and 26.5K fragments were recognized by MAb RS-348. These two fragments correspond to amino acids 137 to 314 and 137 to 341, respectively, the latter is derived from an incomplete digestion. NH2OH cleaves between amino acids 183 to 184 and 437 to 438. The fragments resulting from complete and incomplete digestion of the F1 protein are 5.1K (residues 137 to 183), 15K (residues 438 to 574), 28K (residues 184 to 437), 33K (residues 137 to 437) and 43K (residues 184 to 574). The reactivity of the 33K and 43K fragments with RS-348 MAb indicates that its epitope is located within the sequence from amino acids 184 to 437. HC1 cleaves between amino acids 479 and 480. MAb RS-348 recognized the 39K fragment but did not recognize the 10-5K fragment. From the immunoreactivity of MAb RS-348 with fragments yielded by the different cleavages, we located the epitope of this antibody within the amino acid sequence 184-Gly to 314-Trp.
With these results and the prediction of hydrophobicity, flexibility, occurrences of fl-turns and secondary structure (Garnier et al., 1978; Hopp & Woods, 1981; Janin, 1979; Karplus & Shulz, 1985) we located three potential antigenic domains at positions 208-Asn to 216-Asn, 222-Glu to 240-Asn and 262-Asn to 277-Asn. We then prepared 12 synthetic peptides with sequences pertaining to these areas (Table 1) .
Reactivity of anti-RS virus rabbit serum and 3/IAbs with synthetic peptides of the F protein
The reactivity of anti-RS virus rabbit serum and MAbs with peptides was first investigated in a direct EL1SA. The anti-RS virus rabbit serum was used in a 200-fold dilution, the mouse ascitic fluid in a 100-fold dilution and 
Inhibition studies
The specificity of peptide-antibody interaction was investigated by inhibiting the binding of antibody on a solid-phase peptide or F protein, and by inhibiting the neutralizing activity of the anti-RS virus rabbit serum using soluble peptide. The peptides 205-225 and 259-278 were used in these inhibition experiments. Both soluble peptides inhibited the antibody binding to the solidphase F protein in a competitive ELISA (Fig. 2) . Likewise, the peptides 205-225 and 259-278 inhibited the neutralizing activity of the anti-RS virus rabbit serum (Fig. 3) . In addition to reacting in these assays measuring competition between antibodies and peptides, the anti-peptide 205-225 rabbit serum was successful in inhibiting MAb RS-348 binding to coated IF protein in ELISA (Fig. 4) .
Neutralization activity of anti-peptide 205-225 sera
The peptide 205-225, which showed a positive reaction with anti-RS virus rabbit serum and MAb RS-348, was investigated for its capacity to elicit antibodies recognizing RS virus and F protein in rabbits and mice. Mice were immunized with peptide coupled to BSA or noncoupled and rabbits were immunized with peptide coupled to BSA as described in Methods. The antibody titres were determined by ELISA using three different solid phases: peptide 205-225, F protein or RS virus. No significant differences in antibody titres were noted between mice immunized with coupled or uncoupled peptide. The antibody titres were more or less twice as high on a solid-phase peptide than a solid-phase F protein or RS virus (Table 3) . Anti-peptide 205-225 rabbit serum was investigated for its capacity to neutralize infection by RS virus in vitro. The antipeptide antibody titres determined in a neutralization assay were similar to those elicited from immunization with RS virus (Table 3) .
Discussion
The synthetic peptides used in this study were chosen by the reactivity of chemical and enzymic cleavage products of the F1 protein with MAbs and antiserum and by antigenicity probabilities deduced from a computer program. The reactivity of 12 synthetic peptides, belonging to a region containing amino acid residues 184 to 314, was analysed with MAbs and anti-RS virus rabbit serum. Polyclonal serum did not permit us to define one epitope as precisely as an MAb could, because it included antibodies which had different specificities. However the anti-RS virus rabbit serum, which reacted with four of the 12 peptides, allowed us to define two major antigenic domains, each made up of one or more epitopes. These two antigenic domains, corresponding to the amino acids 200 to 225 and 259 to 278, were centred on a predictive antigenic area. Each antigenic domain included at least one epitope reacting with neutralizing antibodies present in the anti-RS virus rabbit serum. Furthermore the synthetic peptides 205-225 and 259-278 were able to inhibit the neutralizing activity of this anti-RS virus rabbit serum.
The capacity of the peptide 259-278 to react with neutralizing antiserum was in accordance with the results recently published by L6pez et al. (1990) . According to these authors, the integrity of one epitope reacting with a neutralizing MAb required the presence of the asparagine residues located at positions 262 and 268. Nevertheless, the absence of reactivity with the peptide 262-278 led us to conclude that this condition was insufficient. Our data showed that at least one of the three amino acids 259-Ser, 260-Leu and 261-Ile was either involved in the immunological binding with antibodies or contributed to the conformation of the epitope.
As far as the first antigenic domain is concerned, we can offer no explanation for the discrepancies between the observations reported in the present paper and those published by Trudel et al. (1987) . These authors demonstrated that the dodecapeptide 221-11e to 232-Glu mimicked a major part of the neutralization epitope.
This sequence was close to the antigenic domain described here and thus could be involved in a larger immunodominant region. However, under our conditions the two peptides, 218-234 and 221-232, corresponding to this sequence did not react with either the anti-RS virus rabbit serum or with our MAbs. Moreover, like Levely et al. (1990) , we were not able to induce antipeptide 221-232 serum which recognized the F protein or RS virus-infected cells.
In several viruses (Kusters et al., 1989 ) different antigenic structures have been described corresponding to sequential epitopes of a hexapeptide or decapeptide, and conformational and discontinuous epitopes which are not usually reproduced by short synthetic peptides. The reactivity observed with the peptides showed that the epitope recognized by MAb RS-348 was a continuous determinant. However, it needed the integrity of the Up to this stage, synthetic peptides were used to study the antigenicity but not the immunogenicity of the F protein. For this latter analysis, most studies used recombinant viruses expressing the F protein. It has been well demonstrated that vaccination with such protein results in the induction of neutralizing antibodies and a significant reduction in the titre of RS virus in lung tissue after challenge (Brideau et al., 1989; Olmsted et al., 1986; Stott et al., 1987; Wertz et al., 1987) . The results reported here show that defined synthetic peptides also induce neutralizing antibodies and could be used as an alternative in selectively exploring the immunogenicity of the F protein. Both peptides 205-225 and 259-278 inhibited the activity of neutralizing antibodies, but only peptide 205-225 was further analysed for its capacity to induce antibodies specifically recognizing F protein and whole virus in mice and rabbits. Such antibodies were obtained by immunization of rabbits with peptide 205-225 conjugated to BSA or mice with the peptide both conjugated and non-conjugated. The success of this latter kind of immunization indicates that this peptide possesses both antigenic reactivity and immunogenicity. This was probably due to the presence of B lymphocytes and T helper epitopes on this peptide, but this hypothesis requires further investigation. In addition to these properties, immunization with peptide 205-225 stimulated serum antibodies neutralizing RS virus in vitro. The levels of the serum neutralizing antibodies were similar to those obtained by immunization with RS virus. Although these levels seem moderate, it might be interesting to investigate the capacity of these peptides to induce protection in animals after experimental infection.
To sum up, the study reported here shows that two antigenic domains of the F l protein react with neutralizing antibodies. At least one of these is able to induce neutralizing antibodies. Future work will not only examine the protective effects with these peptides, but will investigate specifically the immune response to RS virus infection.
